Money Control | US BioSecure Act: Impact on India and Biotech Opportunities in Supply Chain Shifts

Advanced Biology
Written By Anisree Suresh

The BioSecure Act seeks to reduce US-China biotech ties, creating the potential for India to become a biomanufacturing hub. However, India's biotech sector must overcome challenges in innovation, regulatory standards, and technology to attract businesses shifting from China.

By Anisree Suresh

Read the full article here.

Anisree Suresh
Previous

The Hindu | Implications of the AI Diffusion Framework
Next

Firstpost | Paris AI Summit: How Indo-French partnership can be a rule maker for future innovations